A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
Active, not recruiting · NCT06618001 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Active, not recruiting | Phase 1 | 2026-09-25 | NCT06618001 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Janssen Research & Development, LLC | 188 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Addenbrookes Hospital | Cambridge | United Kingdom | 3 |
| Arthur J E Child Comprehensive Cancer Centre | Calgary | Canada | 50 |
| Clinica Univ. de Navarra | Pamplona | Spain | 42 |
| Hosp Clinic de Barcelona | Barcelona | Spain | 37 |
| Hosp Univ Fund Jimenez Diaz | Madrid | Spain | 33 |
| Princess Margaret Hospital | Toronto | Canada | 4 |
| The Christie NHS Foundation Trust Christie Hospital | Manchester | United Kingdom | 9 |
| University College London Hospitals | London | United Kingdom | 7 |
| Vancouver General Hospital | Vancouver | Canada | 53 |